The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.

Authors:
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA and 6 more

Journal:
Med J Aust

Publication Year: 2022

DOI:
10.5694/mja2.51619

PMCID:
PMC9350119

PMID:
35781813

Journal Information

Full Title: Med J Aust

Abbreviation: Med J Aust

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests No relevant disclosures."

Evidence found in paper:

"AusVaxSafety surveillance is funded under a contract with the Australian Department of Health. Thomas Snelling and Nicholas Wood are supported by Career Development Fellowships from the National Health and Medical Research Council. We acknowledge the participants and staff at the surveillance sites, state and territory health departments, and the contribution of the surveillance tools SmartVax, Vaxtracker, and Microsoft COVID Vaccine Management System."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025